Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Olodaterol + Tiotropium in Healthy Volunteers
NCT02259946Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2006
- Primary completion
- Jul 2006
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing BI 1744 CL + Tiotropium with Placebo (2 arms). Primary endpoints: Number of participants with abnormal findings in physical examination up to 12 days, Number of participants with abnormal changes in laboratory parameters up to 12 days and 10 more. Started Apr 2006; status: completed.
02
Drugs
olodaterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02259946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259946.